Opko Health Inc (OPK) - Total Liabilities
Based on the latest financial reports, Opko Health Inc (OPK) has total liabilities worth $645.29 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See OPK days of operational coverage to measure how many days the company can operate on defensive assets alone.
Opko Health Inc - Total Liabilities Trend (1995–2025)
This chart illustrates how Opko Health Inc's total liabilities have evolved over time, based on quarterly financial data. Check OPK financial resilience to evaluate the company's liquid asset resilience ratio.
Opko Health Inc Competitors by Total Liabilities
The table below lists competitors of Opko Health Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bolsa Mexicana de Valores S.A.B. de C.V
MX:BOLSAA
|
Mexico | MX$1.53 Billion |
|
Chongqing Department Store Co Ltd
SHG:600729
|
China | CN¥11.41 Billion |
|
Blue Dart Express Limited
NSE:BLUEDART
|
India | Rs-17.77 Billion |
|
Sensirion Holding AG
SW:SENS
|
Switzerland | CHF77.55 Million |
|
Fujian Dongbai Group Co Ltd
SHG:600693
|
China | CN¥10.14 Billion |
|
Zhejiang Wanliyang Transmission Co Ltd
SHE:002434
|
China | CN¥3.39 Billion |
|
Vossloh AG
F:VOS
|
Germany | €1.38 Billion |
|
Cadre Holdings Inc
NYSE:CDRE
|
USA | $543.62 Million |
Liability Composition Analysis (1995–2025)
This chart breaks down Opko Health Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see OPK asset base.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.35 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.54 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Opko Health Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Opko Health Inc (1995–2025)
The table below shows the annual total liabilities of Opko Health Inc from 1995 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $663.99 Million | -20.46% |
| 2024-12-31 | $834.76 Million | +34.10% |
| 2023-12-31 | $622.48 Million | +2.79% |
| 2022-12-31 | $605.61 Million | -15.25% |
| 2021-12-31 | $714.59 Million | -10.84% |
| 2020-12-31 | $801.51 Million | +15.41% |
| 2019-12-31 | $694.50 Million | +5.26% |
| 2018-12-31 | $659.80 Million | -11.59% |
| 2017-12-31 | $746.33 Million | +10.60% |
| 2016-12-31 | $674.80 Million | -17.69% |
| 2015-12-31 | $819.80 Million | +89.81% |
| 2014-12-31 | $431.90 Million | -16.71% |
| 2013-12-31 | $518.54 Million | +499.12% |
| 2012-12-31 | $86.55 Million | +26.15% |
| 2011-12-31 | $68.61 Million | +25.21% |
| 2010-12-31 | $54.79 Million | +84.47% |
| 2009-12-31 | $29.70 Million | +38.77% |
| 2008-12-31 | $21.41 Million | -6.05% |
| 2007-12-31 | $22.78 Million | +3280.42% |
| 2006-12-31 | $674.00K | +143.32% |
| 2005-12-31 | $277.00K | +15.90% |
| 2004-12-31 | $239.00K | -76.97% |
| 2003-12-31 | $1.04 Million | -27.97% |
| 2002-12-31 | $1.44 Million | -4.19% |
| 2001-12-31 | $1.50 Million | -6.18% |
| 2000-12-31 | $1.60 Million | -15.59% |
| 1999-12-31 | $1.90 Million | +18.69% |
| 1998-12-31 | $1.60 Million | -5.88% |
| 1997-12-31 | $1.70 Million | +6.25% |
| 1996-12-31 | $1.60 Million | +6.67% |
| 1995-12-31 | $1.50 Million | -- |
About Opko Health Inc
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigen… Read more